Aidan Power
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Dementia and Cognitive Impairment Research
- Bipolar Disorder and Treatment
Papers in
-
- Dementia and Cognitive Impairment Research 7
- Schizophrenia research and treatment 2
- Physiology 11
- Alzheimer's disease research and treatments 11
- Co-authors
- Martin Tolar (15 shared papers)Susan R. Abushakra (15 shared papers)John A. Hey (13 shared papers)Steven Richard Hirsch (1 shared paper)Werner Kissling (1 shared paper)Josef Bäuml (1 shared paper)Yongxin Yu (7 shared papers)Petr Kočiš (3 shared papers)
- Journals
- Drugs (3 papers)Alzheimer s & Dementia (3 papers)International Journal of Molecular Sciences (2 papers)Alzheimer s & Dementia Translational Research & Clinical Interventions (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- United StatesUnited KingdomCzechia
In The Last Decade
Aidan Power
23 papers receiving 593 citations
Aidan Power's Hit Papers
Peers
Comparison fields: 5 of 79
- Biological Psychiatry 46
- Psychiatry and Mental health 176
- Physiology 272
- Pharmacology 154
- Neurology 42
Countries citing papers authored by Aidan Power
This map shows the geographic impact of Aidan Power's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidan Power with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidan Power more than expected).
Fields of papers citing papers by Aidan Power
This network shows the impact of papers produced by Aidan Power. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidan Power. The network helps show where Aidan Power may publish in the future.
Co-authors
The 25 scholars most cited alongside Aidan Power, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression Hit paper breakdown → | 2021 | 173 |
| 2 | 2002 | 129 | |
| 3 | 2017 | 100 | |
| 4 | 2018 | 53 | |
| 5 | 2014 | 30 | |
| 6 | 2020 | 24 | |
| 7 | 2024 | 22 | |
| 8 | 2006 | 20 | |
| 9 | 2022 | 15 | |
| 10 | 2024 | 12 | |
| 11 | 2024 | 12 | |
| 12 | 2025 | 7 | |
| 13 | 2010 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2016 | 3 | |
| 17 | 2017 | 3 | |
| 18 | 2005 | 3 | |
| 19 | 2015 | 2 | |
| 20 | 2023 | 2 |
About Aidan Power
Aidan Power is a scholar working on Psychiatry and Mental health, Physiology, Pharmacology, Pharmacology and Biological Psychiatry, having authored 27 papers that have together received 633 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Schizophrenia research and treatment (2 papers), Cinema and Media Studies (2 papers) and Tryptophan and brain disorders (1 paper). The work is most often cited by research in Biological Psychiatry (46 citations), Psychiatry and Mental health (176 citations), Physiology (272 citations), Pharmacology (154 citations) and Neurology (42 citations). Aidan Power has collaborated with scholars based in United States, United Kingdom and Czechia. Frequent co-authors include Martin Tolar, Susan R. Abushakra, John A. Hey, Steven Richard Hirsch, Werner Kissling, Josef Bäuml, Yongxin Yu, Petr Kočiš, Mark Versavel and Paul L. Kaplan. Their work appears in journals such as Drugs, Alzheimer s & Dementia, International Journal of Molecular Sciences, Alzheimer s & Dementia Translational Research & Clinical Interventions and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.